Pharmacotherapy Review of Chronic Pediatric Hypertension

Schiel, 2006, Overweight, obesity, and elevated blood pressure in children and adolescents, Eur J Med Res, 11, 97 Sorof, 2004, Overweight, ethnicity, and the prevalence of hypertension in school-aged children, Pediatrics, 113, 475, 10.1542/peds.113.3.475 2004, The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents, Pediatrics, 114, 555, 10.1542/peds.114.2.S2.555 Chobanian, 2003, The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report, JAMA, 289, 2560, 10.1001/jama.289.19.2560 Flynn, 2008, Blood pressure in children with chronic kidney disease, Hypertension, 52, 631, 10.1161/HYPERTENSIONAHA.108.110635 Sinaiko, 2002, Relation of insulin resistance to blood pressure in childhood, J Hypertens, 20, 509, 10.1097/00004872-200203000-00027 Lexi-Comp I. Pediatric Lexi-Drugs Online [database on the Internet]. 2010; Accessed December 13, 2010. Thomson Reuters (Healthcare) Inc. Micromedex Healthcare Series [database on the Internet]. Sinaiko, 1983, Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease, J Pediatr, 103, 799, 10.1016/S0022-3476(83)80490-9 Mirkin, 1985, Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the international collaborative study group, Pediatrics, 75, 1091, 10.1542/peds.75.6.1091 Sinaiko, 1986, Antihypertensive drug therapy with captopril in children and adolescents, Clin Exp Hypertens A, 8, 829, 10.3109/10641968609046601 Bouissou, 1986, Long term therapy by captopril in children with renal hypertension, Clin Exp Hypertens A, 8, 841, 10.3109/10641968609046602 O'Dea, 1988, Treatment of neonatal hypertension with captopril, J Pediatr, 113, 403, 10.1016/S0022-3476(88)80292-0 Tack, 1988, Renal failure in sick hypertensive premature infants receiving captopril therapy, J Pediatr, 112, 805, 10.1016/S0022-3476(88)83213-X Wells, 2002, A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension, J Clin Pharmacol, 42, 870, 10.1177/009127002401102786 Soffer, 2003, A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension, Am J Hyperten, 16, 795, 10.1016/S0895-7061(03)00900-2 Soergel, 2000, Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension, Pediatr Nephrol, 15, 113, 10.1007/s004670000422 Wühl, 2004, Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure, Kidney Int, 66, 768, 10.1111/j.1523-1755.2004.00802.x Wühl, 2009, Strict blood-pressure control and progression of renal failure in children, N Engl J Med, 361, 1639, 10.1056/NEJMoa0902066 Sabroe, 1997, Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema, Br J Dermatol, 136, 153, 10.1111/j.1365-2133.1997.tb14887.x Li, 2004, Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?, Hypertension, 44, 289, 10.1161/01.HYP.0000138069.68413.f0 Menon, 2006, Racial differences are seen in blood pressure response to fosinopril in hypertensive children, Am Heart J, 152, 394, 10.1016/j.ahj.2005.12.025 Ellis, 2004, Antihypertensive and renoprotective efficacy and safety of losartan, Am J Hypertens, 17, 928, 10.1016/j.amjhyper.2004.06.014 Shahinfar, 2005, A double-blind, dose-response study of losartan in hypertensive children, Am J Hypertens, 18, 183, 10.1016/j.amjhyper.2004.09.009 Flynn, 2008, Efficacy and safety of the angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years, Hypertension, 52, 222, 10.1161/HYPERTENSIONAHA.108.111054 von Vigier, 2000, Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease, Eur J Pediatr, 159, 590, 10.1007/s004310000495 Franscini, 2002, Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney disease, Am J Hypertens, 15, 1057, 10.1016/S0895-7061(02)03083-2 Simonetti, 2006, Candesartan cilexetil in children with hypertension or proteinuria: preliminary data, Pediatr Nephrol, 21, 1480, 10.1007/s00467-006-0144-0 Trachtman, 2008, Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years, J Clin Hypertens (Greenwich), 10, 743, 10.1111/j.1751-7176.2008.00022.x Franks, 2008, Candesartan cilexetil effectively reduces blood pressure in hypertensive children, Ann Pharmacother, 42, 1388, 10.1345/aph.1L212 Schaefer, 2010, Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age, J Hypertens, 28, 1083, 10.1097/HJH.0b013e328336b86b Hazan, 2010, A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension, Hypertension, 55, 1323, 10.1161/HYPERTENSIONAHA.109.147702 2009 Pfammatter, 1998, Amlodipine once-daily in systemic hypertension, Eur J Pediatr, 157, 618, 10.1007/s004310050897 Khattak, 1998, Efficacy of amlodipine in pediatric bone marrow transplant patients, Clin Pediatr (Phila), 37, 31, 10.1177/000992289803700105 Rogan, 2000, A randomized prospective crossover trial of amlodipine in pediatric hypertension, Pediatr Nephrol, 14, 1083, 10.1007/s004670000400 Flynn, 2000, Treatment of hypertensive children with amlodipine, Am J Hypertens, 13, 1061, 10.1016/S0895-7061(00)00278-8 von Vigier, 2001, Antihypertensive efficacy of amlodipine in children with chronic kidney diseases, J Hum Hypertens, 15, 387, 10.1038/sj.jhh.1001203 Parker, 2002, Amlodipine therapy in pediatric patients with hypertension, J Am Pharm Assoc, 42, 114, 10.1331/108658002763538152 Flynn, 2004, A randomized placebo-controlled trial of amlodipine in children with hypertension, J Pediatr, 145, 353, 10.1016/j.jpeds.2004.04.009 Flynn, 2005, Efficacy and safety of prolonged amlodipine treatment in hypertensive children, Pediatr Nephrol, 20, 631, 10.1007/s00467-004-1781-9 Andersen, 2006, Preliminary experience with amlodipine in the pediatric population, Am J Ther, 13, 198, 10.1097/01.mjt.0000147593.73888.d5 Flynn, 2002, Isradipine treatment of hypertension in children: a single-center experience, Pediatr Nephrol, 17, 748, 10.1007/s00467-002-0939-6 Trachtman, 2003, Clinical trial of extended-release felodipine in pediatric essential hypertension, Pediatr Nephrol, 18, 548, 10.1007/s00467-003-1134-0 Moncica, 1995, A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension, Arch Dis Childhood, 73, 154, 10.1136/adc.73.2.154 Silverstein, 1999, Use of calcium-channel blockers in pediatric renal transplant recipients, Pediatr Transplant, 3, 288, 10.1034/j.1399-3046.1999.00056.x Griswold, 1978, Propranolol as an antihypertensive agent in children, Arch Dis Childhood, 53, 594, 10.1136/adc.53.7.594 Falkner, 1982, The pharmacodynamic effectiveness of metoprolol in adolescent hypertension, Pediatric Pharmacology, 2, 49 Batisky, 2007, Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience, J Pediatr, 150, 134, 10.1016/j.jpeds.2006.09.034 Sorof, 2002, Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial, Pediatr Nephrol, 17, 345, 10.1007/s00467-002-0851-0 Sinaiko, 1977, Management of severe childhood hypertension with minoxidil: a controlled clinical study, J Pediatr, 91, 138, 10.1016/S0022-3476(77)80466-6 Sinaiko, 1980, Clinical response of hypertensive children to long-term minoxidil therapy, J Cardiovasc Pharmacol, 2, S181, 10.1097/00005344-198000022-00012 Puri, 1983, Severe hypertension in children with renal disease: treatment with minoxidil, Am J Kidney Dis, 3, 71, 10.1016/S0272-6386(83)80014-6 Strife, 1986, Minoxidil for control of acute blood pressure elevation in chronically hypertensive children, Pediatrics, 78, 861, 10.1542/peds.78.5.861 Brown, 1998, Angiotensin-converting enzyme inhibitors, Circulation, 97, 1411, 10.1161/01.CIR.97.14.1411 1997, Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy, Lancet, 349, 1857, 10.1016/S0140-6736(96)11445-8 Ruggenenti, 1998, Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow–up trial, Lancet, 352, 1252, 10.1016/S0140-6736(98)04433-X White, 2003, Antiproteinuric effects of enalapril and losartan: a pilot study, Pediatr Nephrol, 18, 1038, 10.1007/s00467-003-1190-5 Friedman, 1983, Effect of captopril on the renin-angiotensin system in hypertensive children, J Pediatr, 103, 806, 10.1016/S0022-3476(83)80491-0 Sagat, 1986, Treatment of renal hypertension in children by captopril, Clin Exp Hypertens A, 8, 853, 10.3109/10641968609046604 Callis, 1986, Long-term treatment with captopril in pediatric patients with severe hypertension and chronic renal failure, Clin Exp Hypertens A, 8, 847, 10.3109/10641968609046603 Rosendahl, 1980, Successful acute and long-term treatment of renin-induced hypertension in two infants with captopril, Eur J Pediatrics, 135, 161, 10.1007/BF00441635 Oberfield, 1982, Long-term treatment of childhood hypertension with captopril, Pediatr Ann, 11, 614, 10.3928/0090-4481-19820701-11 Hogg, 2007, A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension, Pediatr Nephrol, 22, 695, 10.1007/s00467-006-0399-5 Raes, 2007, Lisinopril in paediatric medicine: a retrospective chart review of long-term treatment in children, J Renin-Angiotensin-Aldosterone System, 8, 3, 10.3317/jraas.2007.004 Wells, 2001, The pharmacokinetics of enalapril in children and infants with hypertension, J Clin Pharmacol, 41, 1064, 10.1177/00912700122012661 Saini, 2009, Effect of medication dosing frequency on adherence in chronic diseases, Am J Manag Care, 15, e22 Blumer, 2003, Pharmacokinetics of quinapril in children: assessment during substitution for chronic angiotensin-converting enzyme inhibitor treatment, J Clin Pharmacol, 43, 128, 10.1177/0091270002239820 Li, 2008, Racial differences in blood pressure response to angiotensin-converting enzyme inhibitors in children: a meta-analysis, Clin Pharmacol Ther, 84, 315, 10.1038/clpt.2008.113 Schilder, 1995, Use of enalapril in neonatal hypertension, Acta Paediatrica, 84, 1426, 10.1111/j.1651-2227.1995.tb13581.x Hricik, 1983, Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney, N Engl J Med, 308, 373, 10.1056/NEJM198302173080706 Overlack, 1996, ACE Inhibitor-induced cough and bronchospasm, Drug Safety, 15, 72, 10.2165/00002018-199615010-00006 Israili, 1992, Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy, Ann Intern Med, 117, 234, 10.7326/0003-4819-117-3-234 Baker-Smith, 2010, Cough in pediatric patients receiving angiotensin-converting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized controlled trials, Clin Pharmacol Ther, 87, 668, 10.1038/clpt.2009.231 von Vigier, 2000, Cough is common in children prescribed converting enzyme inhibitors, Nephron, 84, 98, 10.1159/000045552 Vleeming, 1998, ACE inhibitor-induced angioedema, Drug Safety, 18, 171, 10.2165/00002018-199818030-00003 Malde, 2007, Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, Ann Allergy Asthma Immunol, 98, 57, 10.1016/S1081-1206(10)60860-5 Hanssens, 1991, Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy, Obstetrics Gynecol, 78, 128 Ram, 2008, Angiotensin receptor blockers: current status and future prospects, Am J Med, 121, 656, 10.1016/j.amjmed.2008.02.038 Lewis, 2001, Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes, N Engl J Med, 345, 851, 10.1056/NEJMoa011303 Brenner, 2001, Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, N Engl J Med, 345, 861, 10.1056/NEJMoa011161 Seeman, 2009, Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with angiotensin-converting enzyme inhibitors, Kidney Blood Pressure Res, 32, 440, 10.1159/000266478 Herder, 2010, Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents, Pediatr Nephrol, 25, 801, 10.1007/s00467-009-1346-z Ellis, 2003, Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria, J Pediatr, 143, 89, 10.1016/S0022-3476(03)00279-8 Blumer, 2009, Pharmacokinetics of valsartan in pediatric and adolescent subjects with hypertension, J Clin Pharmacol, 49, 235, 10.1177/0091270008329547 Habtemariam, 2009, Population pharmacokinetics of valsartan in pediatrics, Drug Metab Pharmacokinetics, 24, 145, 10.2133/dmpk.24.145 Salcedo-Alejos, 2005, Irbesartan reduces creatinine clearance in type 1 diabetic children with renal hyperfunction: a randomized, double-blind, placebo-controlled trial, Nephrology Dialysis Transplant, 20, 2120, 10.1093/ndt/gfh728 Sakarcan, 2001, The pharmacokinetics of irbesartan in hypertensive children and adolescents, J Clin Pharmacol, 41, 742, 10.1177/00912700122010645 Muir, 2010, Olmesartan medoxomil in children and adolescents with hypertension, Drugs, 70, 2439, 10.2165/11206310-000000000-00000 2011 Meier, 2006, Palatability of angiotensin II antagonists among nephropathic children, Br J Clin Pharmacol, 63, 628, 10.1111/j.1365-2125.2006.02814.x Burnier, 2000, Angiotensin II receptor antagonists, Lancet, 355, 637, 10.1016/S0140-6736(99)10365-9 Pylypchuk, 1998, ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema, Ann Pharmacother, 32, 1060, 10.1345/aph.17388 Cicardi, 2004, Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment, Arch Intern Med, 164, 910, 10.1001/archinte.164.8.910 Abdi, 2002, Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema, Pharmacotherapy, 22, 1173, 10.1592/phco.22.13.1173.33517 Sahney, 2006, A review of calcium channel antagonists in the treatment of pediatric hypertension, Pediatric Drugs, 8, 357, 10.2165/00148581-200608060-00004 Tallian, 1999, Efficacy of amlodipine in pediatric patients with hypertension, Pediatr Nephrol, 13, 304, 10.1007/s004670050614 Flynn, 2006, Population pharmacokinetics of amlodipine in hypertensive children and adolescents, J Clin Pharmacol, 46, 905, 10.1177/0091270006289844 2006 Nahata, 1999, Stability of amlodipine besylate in two liquid dosage forms, J Am Pharmaceutical Assoc, 39, 375, 10.1016/S1086-5802(16)30454-5 Lyszkiewicz, 2003, Bioavailability of a pediatric amlodipine suspension, Pediatr Nephrol, 18, 675, 10.1007/s00467-003-1088-2 Strauser, 2000, Initial experience with isradipine for the treatment of hypertension in children, South Med J, 93, 287, 10.1097/00007611-200003000-00008 Blowey, 1996, The pharmacokinetics of extended release felodipine in children, Eur J Clin Pharmacol, 50, 147, 10.1007/s002280050083 Robinson, 2005, Pharmacologic treatment of chronic pediatric hypertension, Pediatric Drugs, 7, 27, 10.2165/00148581-200507010-00003 Ishisaka, 1991, Labetalol for treatment of hypertension in a child, Clin Pharmacy, 10, 500 Tafreshi, 1999, Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma, Pharmacotherapy, 19, 974, 10.1592/phco.19.11.974.31575 2009 Kallen, 1980, Hypoglycemia: a complication of treatment of hypertension with propranolol, Clin Pediatr, 19, 567, 10.1177/000992288001900814 Wargo, 2009, A comprehensive review of the loop diuretics: should furosemide be first line?, Ann Pharmacother, 43, 1836, 10.1345/aph.1M177 Ernst, 2009, Use of diuretics in patients with hypertension, N Engl J Med, 361, 2153, 10.1056/NEJMra0907219 Marrs, 2010, Spironolactone management of resistant hypertension, Ann Pharmacother, 44, 1762, 10.1345/aph.1P338 Aranda, 1982, Metabolism and renal elimination of furosemide in the newborn infant, J Pediatr, 101, 777, 10.1016/S0022-3476(82)80319-3 Peterson, 1980, Pharmacology of furosemide in the premature newborn infant, J Pediatr, 97, 139, 10.1016/S0022-3476(80)80154-5 Tuck, 1983, Plasma and urinary kinetics of furosemide in newborn infants, J Pediatr, 103, 481, 10.1016/S0022-3476(83)80433-8 Mirochnick, 1988, Furosemide pharmacokinetics in very low birth weight infants, J Pediatr, 112, 653, 10.1016/S0022-3476(88)80192-6 2009 2008 Sica, 2004, Minoxidil: an underused vasodilator for resistant or severe hypertension, J Clin Hypertens (Greenwich), 6, 283, 10.1111/j.1524-6175.2004.03585.x Kandler, 2010, Hydralazine for essential hypertension, Cochrane Database Syst Rev, 10.1002/14651858.CD004934.pub3 2009 2010 Halling, 2010, Minoxidil therapy in children and young adult patients with renal disease and refractory hypertension: value when multidrug regimens have failed to achieve blood pressure control, J Hum Hypertens, 24, 552, 10.1038/jhh.2010.40 Benjamin, 2008, Pediatric antihypertensive trial failures: analysis of end points and dose range, Hypertension, 51, 834, 10.1161/HYPERTENSIONAHA.107.108886 2002 Flynn, 2006, Pharmacologic treatment of hypertension in children and adolescents, J Pediatr, 149, 746, 10.1016/j.jpeds.2006.08.074